newsfilter
← Latest News
GlobeNewswire·

Diffusion Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $30 Million

CHARLOTTESVILLE, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative clinical stage biopharmaceutical company...